Histologic regression of fibrillary glomerulonephritis: the first report of biopsy-proven spontaneous resolution of disease

被引:8
|
作者
Sekulic, Miroslav [1 ]
Nasr, Samih H. [2 ]
Grande, Joseph P. [2 ]
Cornell, Lynn D. [2 ]
机构
[1] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[2] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
来源
CLINICAL KIDNEY JOURNAL | 2017年 / 10卷 / 06期
关键词
diabetic nephropathy; fibrillary glomerulopathy; immune complex glomerulonephritis; immunosuppressive therapy; kidney biopsy; STEM-CELL TRANSPLANTATION; IMMUNOTACTOID GLOMERULOPATHY; RENAL-TRANSPLANTATION; PATHOLOGICAL FEATURES; MONOCLONAL GAMMOPATHY; RITUXIMAB TREATMENT; CLINICAL-FEATURES; DEPOSITS;
D O I
10.1093/ckj/sfx045
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Fibrillary glomerulonephritis (FGN) is a rare immune complex type glomerulonephritis characterized by glomerular deposition of randomly oriented fibrils measuring 10-30nm in thickness, and typically presents with proteinuria with or without renal insufficiency and hematuria. We present a case in which a patient initially presented at age 41 years with nephrotic-range proteinuria and hypertension; a kidney biopsy showed FGN. The patient was treated with angiotensin receptor blockage only, without immunosuppression as per patient preference, and the level of protein in the urine improved. During the follow-up period of 17 years, the patient developed type 2 diabetes mellitus. The patient re-presented with nephrotic-range proteinuria 17 years later, at the age of 58 years. A kidney biopsy was performed and showed diffuse diabetic glomerulosclerosis with secondary focal segmental glomerulosclerosis and related vascular changes. There was no evidence of FGN by immunofluorescence or electron microscopy. Although FGN has been rarely reported to regress clinically, this is the first documented case of histologic regression of FGN. The potential for FGN fibrils to regress spontaneously is important in the management of FGN patients considering that currently available immunosuppressive agents have limited efficacy, and is an encouraging finding for future studies aiming to find a cure for the disease.
引用
收藏
页码:738 / 741
页数:4
相关论文
共 50 条
  • [1] Incidence of biopsy-proven glomerulonephritis
    Wirta, Ole
    Mustonen, Jukka
    Helin, Heikki
    Pasternack, Amos
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (01) : 193 - 200
  • [2] Biopsy-Proven Spontaneous Regression of a Rhabdomyomatous Mesenchymal Hamartoma
    Mazza, Joni M.
    Linnell, Erica
    Votava, Henry J.
    Wisoff, Jeffrey H.
    Silverberg, Nanette B.
    PEDIATRIC DERMATOLOGY, 2015, 32 (02) : 256 - 262
  • [3] The incidence of biopsy-proven glomerulonephritis in Australia
    Briganti, EM
    Dowling, J
    Finlay, M
    Hill, PA
    Jones, CL
    Kincaid-Smith, PS
    Sinclair, R
    McNeil, JJ
    Atkins, RC
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (07) : 1364 - 1367
  • [4] Epidemiology of biopsy-proven glomerulonephritis in Queensland adults
    Jegatheesan, Dev
    Nath, Karthik
    Reyaldeen, Reza
    Sivasuthan, Goutham
    John, George T.
    Francis, Leo
    Rajmokan, Mohana
    Ranganathan, Dwarakanathan
    NEPHROLOGY, 2016, 21 (01) : 28 - 34
  • [5] Incidence of biopsy-proven primary glomerulonephritis in an Italian province
    Stratta, P
    Segoloni, GP
    Canavese, C
    Sandri, L
    Mazzucco, G
    Roccatello, D
    Manganaro, M
    Vercellone, A
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (05) : 631 - 639
  • [6] SPONTANEOUS RESOLUTION OF HYPERPROLACTINEMIA RESULTING FROM BIOPSY-PROVEN SELECTIVE AUTOABLATION OF A PROLACTINOMA
    KRCEK, JP
    MACRAE, E
    CORENBLUM, B
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1987, 14 (02) : 226 - 226
  • [7] AGE-RELATED DIFFERENCES IN THE SPECTRUM OF BIOPSY-PROVEN GLOMERULONEPHRITIS
    Capusa, Cristina-Stela
    Pana, Nicolae
    Popa, Otilia
    Chiotan, Laura
    Mandache, Eugen
    Lipan, Mariana
    Dumitru, Daniela
    Mircescu, Gabriel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 742 - 742
  • [8] Biopsy-proven Streptococcus suis-associated Infectious Glomerulonephritis
    Kajitani, Hideto
    Nishiwaki, Hiroki
    Ueno, Toshiharu
    Koiwa, Fumihiko
    Iwasaki, Shigeki
    Hirade, Satoshi
    INTERNAL MEDICINE, 2022, 61 (08) : 1201 - 1204
  • [9] Clinical Outcomes of Kidney Transplantation in Patients With Biopsy-Proven Glomerulonephritis
    Park, H.
    Park, W. Y.
    Kang, S. S.
    Yeo, S. M.
    Han, S.
    Park, S. B.
    Jin, K.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (04) : 1009 - 1012
  • [10] Biopsy-proven resolution of immune complex-mediated crescentic glomerulonephritis with mycophenolate mofetil therapy in an allograft
    Adams, PL
    Iskandar, SS
    Rohr, MS
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (03) : 552 - 554